SKF 83959 is an antagonist of dopamine D1-like receptors in the prefrontal cortex and nucleus accumbens: a key to its antiparkinsonian effect in animals?
- 28 February 2002
- journal article
- Published by Elsevier in Neuropharmacology
- Vol. 42 (2) , 237-245
- https://doi.org/10.1016/s0028-3908(01)00169-1
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- SKF83959 exhibits biochemical agonism by stimulating [35S]GTPγS binding and phosphoinositide hydrolysis in rat and monkey brainNeuropharmacology, 2001
- The predictive validity of the drug-naive bilaterally MPTP-treated monkey as a model of Parkinson's diseaseBehavioural Pharmacology, 1999
- The validity of the pretreated, unilaterally MPTP-treated monkey as a model of Parkinson's diseaseBehavioural Pharmacology, 1999
- Relationship between dopamine agonist stimulation of inositol phosphate formation and cytidine diphosphate–diacylglycerol accumulation in brain slicesBrain Research, 1999
- Blockade of D‐1 dopamine receptors in the medial prefrontal cortex produces delayed effects on pre‐ and postsynaptic indices of dopamine function in the nucleus accumbensSynapse, 1994
- Role of the Nucleus Accumbens and the Striatum in the Production of Turning Behaviour in Intact RatsReviews in the Neurosciences, 1994
- Locomotor activity following intra‐accumbens microinjections of dopamine D1 agonist SK&F 38393 in ratsSynapse, 1993
- Molecular Diversity of the Dopamine ReceptorsAnnual Review of Pharmacology and Toxicology, 1993
- Opposing roles for D-1 and D-2 dopamine receptors in efflux of cyclic AMP from rat neostriatumNature, 1981
- Effect of 6‐Hydroxydopamine Lesions of the Medial Prefrontal Cortex on Neurotransmitter Systems in Subcortical Sites in the RatJournal of Neurochemistry, 1980